Artificial Intelligence | Machine Learning | Machine Perception Unlearn.ai | Accelerating Clinical Trials with AI


Enterprise, Biotechnology, Pharmaceuticals, Clinical Trials, Clinical Research, Data Science San Francisco, CA, United States

Unlearn.ai

Artificial Intelligence | Machine Learning | Machine Perception


Unlearn.ai | Accelerating Clinical Trials with AI

Unlearn.ai

Biotechnology, Pharmaceuticals, Clinical Trials, Clinical Research, Data Science


San Francisco, CA, United States

Unlearn.AI is a developer of a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies. Creating AI to simulate biology and improve the lives of patients. Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.

 

Enrollment challenges and timeline delays plague clinical trials.

Twintelligent RCTs™ incorporate prognostic information from Digital Twins into randomized controlled trials to enable smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions.

Make trials more patient-centric Clinical trials with smaller control groups are more attractive to patients. Shorten enrollment timelines Twintelligent RCTs™ reach enrollment targets faster because they require fewer patients. Increase power and confidence Twintelligent RCTs™ provide reliable evidence suitable for pivotal clinical trials.

 
 

   Total Funding: N/A

   Funding Stage: Series B

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 51 to 100

   Founded: 2017

Nov 2023

  • Announcing the latest release of our Parkinson’s Disease Digital Twin Generator
 
 

Date

Round

$ Raised

Investors

02/08/2024

Series C

$50M

Altimeter Capital, Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, Necessary Venture Capital

Date : 02/08/2024

Round: Series C

$ Raised: $50M

Investors: Altimeter Capital, Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, Necessary Venture Capital

04/19/2022

Series B

$50M

Insight Partners, Radical Ventures, 8VC, DCVC, Mubadala Capital Ventures

Date : 04/19/2022

Round: Series B

$ Raised: $50M

Investors: Insight Partners, Radical Ventures, 8VC, DCVC, Mubadala Capital Ventures

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Unlearn.ai

 
 
 
Charles Fisher


Charles Fisher
Founder and Chief Executive Officer

Aaron Smith


Aaron Smith
Founder

Julia Coelho


Julia Coelho
Chief Commercial Officer

Graham Siegel


Graham Siegel
COO

Jonathan Walsh


Jonathan Walsh
Founder, Head of Data Science

Dana Jasek

Dana Jasek
Head of Marketing/CMO

 
 

Unlearn.ai is growing. Want to work at Unlearn.ai? Unlearn.ai is hiring. Join team at Unlearn.ai

 

View All

View All AI/ML Jobs

Director of Biostatistics Research

San Francisco, California

Digital Marketing Associate

San Francisco, CA or Remote

Senior DevOps Engineer

San Francisco, California

 
 
appengine.ai

World's Most Promising AI/ML Startups